TASIGNA On Demand Patient Support

The TASIGNA On Demand patient support program provides educational materials about Ph+ CML in chronic phase and TASIGNA® (nilotinib) capsules. It also includes information about saving on the medication for those who have been prescribed TASIGNA.

Sign up for support

Fill out the information below to sign up for TASIGNA On Demand. Be sure to click the “Submit” button. You must be 18 years of age or older to enroll.

  1. 1/1:Enter Your Information

*Required Field

Are you or a loved one currently taking TASIGNA? *

Did you receive a TASIGNA Patient Starter Kit from your doctor?*

**Treatment-free remission is the possibility for eligible adult patients with Ph+ CML-CP to come off treatment. 

  • Your healthcare provider will monitor your CML during treatment with TASIGNA to see if you are in a remission. After at least 3 years of treatment with TASIGNA, your healthcare provider may do certain tests to determine if you continue to be in remission. Based on your test results, your healthcare provider may decide if you may be eligible to try stopping treatment with TASIGNA. This is called Treatment Free Remission (TFR)
  • Your healthcare provider will carefully monitor your CML during and after you stop taking TASIGNA. Based on your test results, your healthcare provider may need to re-start your TASIGNA if your CML is no longer in remission
  • It is important that you are followed by your healthcare provider and undergo frequent monitoring to find out if you need to re-start your TASIGNA treatment because you are no longer in TFR. Follow your healthcare provider’s instructions about re-starting TASIGNA if you are no longer in TFR

 

Privacy Notice

By clicking "Submit," I agree to the Novartis Pharmaceuticals Corporation Terms of Use. I understand and agree that the information I provide will be used in accordance with the Novartis Privacy Policy, including to provide me with marketing information, offers, and promotions and to contact me for my opinions regarding products, programs, and services. I understand that unless I unsubscribe, by calling 1-800-282-7630 or clicking unsubscribe in a promotional e-mail, my consent will remain valid. I also understand that I may receive nonmarketing calls and texts from and on behalf of Novartis about TASIGNA, including through an autodialer or prerecorded voice, at the telephone number(s) I have provided. 

Please complete all required fields.